Combination therapy to treat osteoporosis - polyphosphonates...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) A61K 31/47 (2006.01) A61K 31/565 (2006.01) A61K 31/57 (2006.01) A61K 31/66 (2006.01)

Patent

CA 2198534

Disclosed is a pharmaceutical composition for preventing or treating osteoporosis containing a compound of formula I (see fig I) (wherein A is CH2 or NR; R is H or alkyl; B, D and E are each CH or N; Y is a cyclic group such as phenyl; Z1 is a divalent group such as -OCH2CH2; G is an optionally substituted amino group such as piperidino or pyrrolidino; and e is 0, 1 or 2) in combination with a polyphosphonate or a progestin.

Composition pharmaceutique pour la prévention ou le traitement de l'ostéoporose, renfermant un composé de formule I (voir fig. I) ¢où A est CH2 ou NR; R est H ou un alkyle; B, D et E sont chacun CH ou N; Y est un groupe cyclique comme le phényle; Z1 est un groupe divalent comme -OCH2CH2; G est un groupe amino avec substitution facultative, comme un pipéridino ou un pyrrolidino; e est 0, 1 ou 2! en combinaison avec un polyphosphonate ou une progestine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy to treat osteoporosis - polyphosphonates... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy to treat osteoporosis - polyphosphonates..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy to treat osteoporosis - polyphosphonates... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1384666

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.